ASH VTE Guidelines: Prevention and Treatment in Patients with Cancer
Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk of morbidity and mortality. These guidelines are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of VTE in patients with cancer.
Access the full guidelines on the Blood Advances website:
Guideline Implementation Tools and Resources
VTE Guidelines: What You Should Know
This one-page snapshot provides a high-level summary of the guidelines on the prevention and treatment of VTE in patients with cancer. A snapshot of the full VTE guidelines is also available for download.
Help your colleagues diagnose, manage, and treat VTE with the following teaching slides designed for easy dissemination:
- Anticoagulation Therapy
- Heparin-Induced Thrombocytopenia (HIT)
- Prevention in Surgical Patients
- Prophylaxis for Medical Patients
- Use of Anticoagulation in COVID-19
- VTE for Latin America